AsortinoBeta
Dr. Reddy's Laboratories Ltd. ADR logo

RDYDr. Reddy's Laboratories Ltd. ADR

$11.970.50%
NYSE · at close Sep 4, 2026
Tokenized by
Reality logo
1 issuerOn
Arbitrum One logoMorph logo
2 chains

Chart data are delayed by 15 minutes.

1D0.50%
1M1.07%
3M9.59%
1Y15.41%
3Y12.04%
5Y10.79%

Main metrics

$9.97B
28.50
$0.42
0.69%
2.6M
0.24
$11.3652-week range$15.67

About RDY

Dr. Reddy’s Laboratories Ltd. ADR is a healthcare and pharmaceutical company that develops, manufactures, and markets a broad portfolio of medicines and related products. The company serves patients and healthcare providers through branded and generic prescription drugs, over-the-counter treatments, active pharmaceutical ingredients, and biosimilars. Its operations also include pharmaceutical services and contract manufacturing activities that support drug development and supply chains. Dr. Reddy’s Laboratories Ltd. ADR participates in therapeutic areas such as gastroenterology, cardiovascular care, diabetes, dermatology, oncology, respiratory medicine, and pain management. Headquartered in Hyderabad, India, the company plays an important role in the global generic medicines market and in the broader healthcare supply chain through its international commercial presence and diversified pharmaceutical offerings.

Similar products

Alkermes plc logo
ALKSNASDAQ
$46.101.66%
Alkermes plc
Reality logo
1 issuer · 2 chains
Elanco Animal Health Incorporated logo
ELANNYSE
$24.50+0.33%
Elanco Animal Health Incorporated
Backed Finance logoReality logo
2 issuers · 11 chains
Hims & Hers Health, Inc. Class A Common Stock logo
HIMSNYSE
$27.710.40%
Hims & Hers Health, Inc. Class A Common Stock
Ondo Finance logoBacked Finance logoRobinhood logo
6 issuers · 15 chains
Haleon Plc ADR logo
HLNNYSE
$9.602.64%
Haleon Plc ADR
Reality logo
1 issuer · 2 chains